This article provides key insights and suggested best practices for managed care to improve patient care in MPS disorders, which may also be relevant to other rare and ultra-rare conditions.
AMCP submits letter to New Jersey Assembly committee opposing Assembly Bill 881- prohibiting utilization management strategies
The Academy of Managed Care Pharmacy (AMCP) is writing in strong opposition to Assembly Bill 881, which would prohibit the use of utilization management, a contractual provision agreed upon by insurers and the employer paying for a prescription medication benefit. The legislation requires coverage for medically necessary prescription medication through the covered person’s entire course of treatment. The time period for the course of treatment shall be determined solely by the covered person’s prescriber without the imposition of any utilization management requirements.
Related
As part of a multi-year RWE initiative, AMCP Research Institute partnered with IQVIA, payers, pharmaceutical companies, and others to design payer-focused RWE standards that were published in JMCP in September, 2025.
AMCP’s guidance translates CMS’s expectations for patient centered, evidence informed formulary decisions into practical steps payers can act on today without adding unnecessary burden to P&T workflows.
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
